On November 17, 2025, Josh Zwagil, founder and CEO of My Daily Choice (MDC), announced a partnership with Immunotec, a science-driven health and wellness company, effectively integrating MDC’s network into Immunotec’s global structure, per Business For Home and Direct Selling News. Zwagil is stepping into the field as an ImmunotecPro, bringing MDC’s $600M in cumulative sales and over 1 million members to bolster Immunotec’s mission of “improving lives through science and human connection,” per. This move follows MDC’s 38,700 monthly website visits in October 2025, signaling a potential pivot amid slowing growth, per SimilarWeb data.
The collaboration merges MDC’s high-velocity field leadership and grassroots momentum with Immunotec’s four decades of scientific excellence, including glutathione-based products. Zwagil, who co-founded MDC in 2014 with his wife Jenna (now separated and linked to a Dubai scheme), emphasized returning to “building with people,” per. Immunotec’s CEO Mauricio Domenzain called it a “union of shared purpose,” per. While terms are opaque, speculation includes an upfront payment to Zwagil with performance bonuses tied to MDC promoters driving Immunotec sales, per industry analysis. No outright acquisition is confirmed, but future rights to MDC assets are possible.
MDC, headquartered in Las Vegas, focuses on health, wellness, and financial education products, reaching $100M in 2018 sales, per Business For Home. Zwagil’s career includes chess mastery at age 12 and tech innovations for MLM firms, per. Recent challenges include a February 2025 lawsuit from Eaconomy’s Hassan Mahmoud, alleging a hostile takeover via Creative Brands (Zwagil-linked), dismissed voluntarily on February 24, 2025, per BehindMLM. Zwagil’s pivot from supplements to securities fraud ventures and MDC Marketplace (selling third-party products) has drawn scrutiny, per. The partnership raises questions about MLM genealogy placement, compensation plans, and Zwagil’s long-term commitment.
This integration could accelerate Immunotec’s growth in direct selling, but opacity on terms—such as wind-down plans for MDC, dual compensation structures, or exit clauses—creates uncertainty for promoters, per. Critics argue it “milks the cow on the way out,” potentially eroding trust if no extra incentives flow to MDC affiliates, per. Immunotec’s dual Instagram profiles (Immunotec and ImmunotecPro) add confusion, per. The MLM sector, valued at $200B globally, sees such mergers as common amid consolidation, but transparency is key to retention.
The deal positions Zwagil for a “new chapter” in a $600M+ ecosystem, per, but unresolved questions on contractual obligations and the future of MDC could impact morale. Investors in MLM should demand clarity on revenue sharing and verify via FTC guidelines at ftc.gov. Diversify into stable sectors like health supplements or crypto (e.g., BTC at $113,234), with stop-losses below $112,000, per TradingView. Follow @DirectSellingNews on X for updates. If successful, this could model MLM evolution, but shadiness risks backlash in 2026.
